Effects of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide 1 Receptor Agonists on Cardiovascular and Limb Events, Primarily in Patients with Peripheral Artery Disease
Section Head, Vascular Medicine; Medical Director, Anticoagulation Clinic; Medical Director, Vein Center; Medical Director, Vascular Laboratories | Allina Health Minneapolis Heart Institute
